Andere Sprachen Glaukos Corporation

Aktien

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 30.05.2024			% 5 Tage	% 1. Jan.
110,7 ^USD	+0,33 %		+3,03 %	+39,26 %

14.05.	Glaukos Insider verkaufte Aktien im Wert von $264.791, laut einer aktuellen SEC Einreichung	MT
06.05.	GLAUKOS CORPORATION : Jefferies & Co. erhöht seine Kaufempfehlung	ZM

Glaukos Announces Participation in Upcoming Investor Conferences	28.05.
Glaukos : 2023 EEO-1 Report	23.05.
Glaukos : Investor Presentation May 2024	20.05.
Glaukos Insider Sold Shares Worth $264,791, According to a Recent SEC Filing	14.05.
Glaukos : Q1 2024 Earnings Transcript	02.05.
Glaukos : Q1 2024 GAAP to Non-GAAP Recs	02.05.
Glaukos : Q1 2024 Quarterly Summary	02.05.
Earnings Flash (GKOS) GLAUKOS CORPORATION Reports Q1 Revenue $85.6M, vs. Street Est of $79.7M	01.05.
Glaukos: Q1 Earnings Snapshot	01.05.
Glaukos Announces First Quarter 2024 Financial Results	01.05.
Glaukos Corporation Raises Earnings Guidance for 2024	01.05.
Glaukos Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	01.05.
Glaukos Announces the Release of its 2023 Sustainability Report	16.04.
Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing	11.04.
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1	10.04.
Sector Update: Health Care Stocks Rise Wednesday Afternoon	03.04.
Glaukos Says iDose TR Assigned Permanent J-Code From US Centers for Medicare and Medicaid Services	03.04.
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)	03.04.
Glaukos Corporation Receives Permanent J-Code for iDose TR (travoprost intracameral implant)	03.04.
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting	01.04.

Keine Ergebnisse zu dieser Suche